STOP
DEAD

Serial Number

88902309

Owner

The Broad Institute Inc.

Attorney

Jennifer S. Stachniak

Filing Date

May 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

STOP Trademark

Serial Number: 88902309

STOP is a trademark filed by The Broad Institute Inc. on May 5, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

The Broad Institute Inc. (46 trademarks)

415 Main Street
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

May 5, 2020

Registration Date

Not Registered

Published for Opposition

March 14, 2023

Goods & Services

RNA-guided therapeutic pharmaceuticals for the treatment of diseases and medical conditions, namely, allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections; diagnostic preparations for medical or veterinary purposes; Reagent paper for medical or veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections; Medical diagnostic reagents and assays for testing of body fluids

Diagnostic preparations for scientific or research use; Reagent paper other than for medical purposes

Disease and pest control treatments for agriculture, namely, breeding and propagating genetically modified plants with increased disease resistance; performing diagnosis of diseases; Medical testing for diagnostic or treatment purposes; Providing medical information from a website; Providing a website featuring information in the field of the diagnosis and treatment of allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 11, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 11, 2023 ABN6
ASSIGNED TO EXAMINER
Jun 21, 2023 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 9, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2023 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 13, 2023 RCCK
ASSIGNED TO EXAMINER
Jan 9, 2023 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 13, 2022 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 6, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 13, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 10, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 10, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 10, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 4, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 4, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 29, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 19, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2020 NWOS
NEW APPLICATION ENTERED
May 8, 2020 NWAP